Volkswagen CEO Oliver Blume called on European policymakers to create supportive frameworks for the automaker's major restructuring amid intense competition from Chinese electric vehicle makers expanding in Europe. At the Paris motor show event, Blume emphasized the need for "Made in Europe" rules to encourage local manufacturing and fair competition. Volkswagen is undergoing a significant transformation, including job cuts and new affordable EV launches, to maintain its market leadership against growing Chinese rivals. The CEO highlighted that fair competition and local job creation are essential for the industry's future in Europe.
The Volkswagen CEO's call for EU support in transformation comes as the Consumer Cyclical sector shows mixed performance on Pluang. Of 126 priced US stocks in this sector, 79 rose and 45 fell as of Oct 11, 2026 23:11 WIB. Notable movers include Stitch Fix Inc (SFIX) at USD 2.84 with a 4.03% increase and Xpeng Inc (XPEV) at USD 9.90 with a 3.66% gain and a typical hold time of 81 days on Pluang.
BridgeBio Pharma announced that encaleret, a treatment for autosomal dominant hypocalcemia type 1 (ADH1), increased bone turnover and improved patient-reported symptoms in the Phase 3 CALIBRATE trial. 100% of patients on encaleret reported symptom im...
Remittix announced its final presale price for the RTX token at $0.46, set as the minimum exchange launch price for its market debut on November 24, 2026. Currently, RTX is available at $0.23 during the ongoing presale stage, with the project nearing...
Monteverde & Associates PC, a top-ranked class action law firm, is investigating the proposed sale of Option Care Health, Inc. to an investor group including Clayton, Dubilier & Rice and McKesson Corporation. The deal offers Option Care shareholders ...
Ethereum hovered around $2,500 on October 11 after a volatile week marked by a broad crypto selloff impacting major assets like Bitcoin and Solana. Analysts highlight the $2,550–$2,600 range as a critical resistance level for Ethereum, with a potenti...
Monteverde & Associates PC, a top class action law firm, is investigating the proposed sale of Pacira BioSciences to Viatris Inc., where Pacira shareholders are set to receive $36.50 per share in cash. The firm is questioning whether this deal is fai...
